San Diego, CA, United States of America

Tien Lee

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Culver City, CA (US) (2019 - 2020)
  • San Diego, CA (US) (2020 - 2023)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Tien Lee: Innovating Cancer Treatment Through Patented Technology

Introduction

Tien Lee, an innovative inventor based in San Diego, CA, has made significant contributions to the field of cancer treatment with her array of patented technologies. With a total of six patents, Lee's work focuses on advanced cellular therapies aimed at enhancing the efficacy of cancer treatments.

Latest Patents

One of her notable inventions is related to modified NK-92 cells for treating cancer, which involves NK-92 cells expressing at least one chimeric antigen receptor (CAR) and at least one Fc receptor. This patented technology includes methods for the treatment of patients diagnosed with or suspected of having treatable diseases like cancer by administering NK-92-Fc-CAR. Another key patent details genetically modified NK-92 cells and monoclonal antibodies specifically designed for the treatment of cancer, further enhancing potential therapeutic outcomes for patients.

Career Highlights

Throughout her career, Tien Lee has worked with leading companies in the biotechnology sector, including NantKwest Inc. and ImmunityBio, Inc. Her endeavors in these organizations have not only spurred her innovations but have also positioned her as a key figure in the development of cutting-edge cancer treatments.

Collaborations

Collaboration has been a hallmark of Lee's career, pairing her expertise with that of renowned professionals such as Hans G. Klingemann and Barry J. Simon. These partnerships have enabled her to merge insights and drive forward the advancement of her research and inventions in cancer therapy.

Conclusion

In conclusion, Tien Lee stands out as an impactful inventor whose work in modifying NK-92 cells is pushing the boundaries of cancer treatment. Her six patents reflect her commitment to innovation and the collaborative spirit that defines her career. As the field of cancer therapy continues to evolve, Lee's inventions promise to play a pivotal role in improving patient outcomes and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…